Metabolism of tryptophan in non-small lung cancer patients with different effect of PD-1 / PD-L1 inhibitors immunotherapy
Introduction. In the structure of cancer incidence, lung cancer ranks first among men. In order to study the molecular mechanisms of the initiation and progression of lung cancer, it is necessary to study not only the tumor cells themselves, but also the features of the systemic tryptophan metabolis...
Saved in:
Main Authors: | E. Yu. Zlatnik, A. B. Sagakyants, I. A. Novikova, A. Yu. Maksimov, O. P. Shatova, S. A. Appolonova, N. E. Moskaleva, S. A. Rumyantsev, A. V. Shestopalov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-06-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/442 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing CAR-T Efficacy: The Role of Anti PD-1/PD-L1 Checkpoint Inhibitors in Modern Cancer Treatment
by: Rishi Kant, et al.
Published: (2025-06-01) -
The predictive value of total body PET/CT in high PD-L1 expression and immunotherapy in advanced non-small cell lung cancer patients
by: Huibin Jin, et al.
Published: (2025-07-01) -
Activity of Negative Regulation of the PD-1/PD-L1/PD-L2 T-Cell Response System in Patients with Pneumonia and Influenza A (H1N1)
by: A. V. Malyarchikov, et al.
Published: (2021-08-01) -
Clinical observation of the efficacy of PD‐1/PD‐L1 inhibitors in the treatment of patients with advanced solid tumors
by: Miao Wang, et al.
Published: (2021-12-01) -
Immunotherapy of cancer tumors with inhibition of PD-1 membrane protein and its ligands interaction
by: A. V. Chetveryakov, et al.
Published: (2021-10-01)